Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Rudi Ross"'
Publikováno v:
Journal of Radiation Oncology. 8:267-278
To study radiotherapeutic treatment approaches in larynx-preservation for T2N0M0 glottic carcinoma at free-standing centers in the USA. We retrospectively audited fractionation and chemoradiation at 59 centers in 5 geographic regions from 2000 to 201
Autor:
Timothy D. Shafman, Roy H. Decker, John M. Stahl, Vivek Verma, Benjamin H. Kann, Henry S. Park, Arie P. Dosoretz, Rudi Ross, Cary P. Gross, James B. Yu
Publikováno v:
Radiotherapy and Oncology. 134:44-49
Purpose Although stereotactic body radiation therapy (SBRT) is the standard of care for inoperable early-stage non-small cell lung carcinoma (NSCLC), its role for medically operable patients remains controversial. To address this knowledge gap, we co
Autor:
Henry S. Park, Cary P. Gross, John M. Stahl, Benjamin H. Kann, Timothy D. Shafman, Roy H. Decker, Joseph A. Miccio, Vivek Verma, James B. Yu, Rudi Ross, Arie P. Dosoretz
Publikováno v:
Radiotherapy and Oncology. 132:188-196
Purpose Although adjuvant systemic therapy (ST) is often recommended for the treatment of patients with high-risk, early-stage non-small cell lung carcinoma (NSCLC) after surgery, there is little evidence supporting the use of ST with stereotactic bo
Autor:
Pamela R. Soulos, Arie P. Dosoretz, Steven E. Finkelstein, Brandon R. Mancini, Timothy D. Shafman, Eileen M. Harder, James B. Yu, John M. Stahl, Cary P. Gross, Rudi Ross, Suzanne B. Evans, Roy H. Decker, Zain A. Husain
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:1011-1020
Purpose To determine the effect of biologically effective dose (BED 10 ) and radiation treatment schedule on overall survival (OS) in patients with early-stage non-small cell lung cancer (NSCLC) undergoing stereotactic body radiation therapy (SBRT).
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 34(3)
High-quality oncology consultation includes patient-oriented communication tailored to patients' individualized needs. Common methods used in studies to increase question-asking are prompt lists and coaching pre-consultations. However, our patients w
Autor:
Arie P. Dosoretz, Julian C. Hong, Xin Hu, Timothy D. Shafman, Elham Rahimy, Suzanne B. Evans, Henry S. Park, Cary P. Gross, James B. Yu, Steven E. Finkelstein, Rudi Ross, Pamela R. Soulos
Publikováno v:
Practical radiation oncology. 8(3)
Adjuvant radiation therapy (RT) for breast cancer improves outcomes, but prior studies have documented substantive cardiac dose and cardiac risk. We assessed the mean heart dose (MHD) of RT and estimated the risk of RT-associated cardiac toxicity in
Autor:
Elham Rahimy, Xin Hu, James B. Yu, Suzanne B. Evans, Timothy D. Shafman, Rudi Ross, Pamela R. Soulos, Julian C. Hong, Cary P. Gross, Henry J. Connor, Arie P. Dosoretz
Publikováno v:
International journal of radiation oncology, biology, physics. 99(5)
Purpose To analyze the relationship between angle number and mean heart dose (MHD) in adjuvant fixed gantry intensity modulated radiation therapy (FG-IMRT) treatment of left-sided breast cancer as is currently practiced in the community. Methods and
Autor:
Michael J. Katin, Brian J. Moran, Michelle H. Braccioforte, Anthony V. D'Amico, Ming-Hui Chen, Rudi Ross, Akash Nanda, Sharon Salenius, Daniel E. Dosoretz
Publikováno v:
European Urology. 65:177-185
Neoadjuvant hormone therapy (NHT) use is associated with an increased risk of all-cause mortality (ACM) in men with a history of coronary artery disease (CAD)-induced congestive heart failure (CHF) or myocardial infarction (MI). However, its effect i
Autor:
Sharon Salenius, Ronald D. Ennis, Rudi Ross, Joshua A. Beckman, Toni K. Choueiri, Jing Ma, Powell L. Graham, Arti Parekh, Ming-Hui Chen, Neil E. Martin, Paul L. Nguyen, Anthony V. D'Amico, Clair J. Beard, Jim C. Hu, Karen E. Hoffman, Daniel E. Dosoretz
Publikováno v:
Brachytherapy. 12:415-421
Purpose To determine which specific comorbidities predispose men to excess mortality by androgen deprivation therapy (ADT) given before and during brachytherapy for prostate cancer. Methods and Materials We analyzed 5972 men with T1c–T3b prostate c
Autor:
Timothy D. Shafman, Christopher R. King, Constantine A. Mantz, Amy M. Dosoretz, Skyler B. Johnson, Sergio Faria, Alan Pollack, Jeffrey V. Brower, James B. Yu, Mark A. Ritter, Mikko Hallman, Matthew C. Abramowitz, Sean P. Collins, Steven E. Finkelstein, Cary P. Gross, Pamela R. Soulos, Patrick A. Kupelian, Simeng Suy, Eric M. Horwitz, Rudi Ross
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 121(2)
Evaluate changes in bowel, urinary and sexual patient-reported quality of life following treatment with moderately hypofractionated radiotherapy (5Gray/fraction) or stereotactic body radiation therapy (SBRT;5-10Gray/fraction) for prostate cancer.In a